Kwon Hyoshin, Sandhu Zoya, Sarwar Zoona, Andacoglu Oya M
Department of Surgery, Division of Transplantation, Ou College of Medicine, OK 73104, United States.
Department of Internal Medicine, University of Oklahoma, Tulsa School of Community Medicine, Tulsa, OK 74135, United States.
World J Transplant. 2024 Sep 18;14(3):92981. doi: 10.5500/wjt.v14.i3.92981.
There is no data evaluating the impact of Medicaid expansion on kidney transplants (KT) in Oklahoma.
To investigate the impact of Medicaid expansion on KT patients in Oklahoma.
The UNOS database was utilized to evaluate data pertaining to adult KT recipients in Oklahoma in the pre-and post-Medicaid eras. Bivariate analysis, Kaplan Meier analysis was used to estimate, and cox proportional models were utilized.
There were 2758 pre- and 141 recipients in the post-Medicaid expansion era. Post-expansion patients were more often non-United States citizens (2.3% 5.7%), American Indian, Alaskan, or Pacific Islander (7.8% 9.2%), Hispanic (7.4% 12.8%), or Asian (2.5% 8.5%) ( < 0.0001). Waitlist time was shorter in the post-expansion era (410 253 d) ( = 0.0011). Living donor rates, pre-emptive transplants, re-do transplants, delayed graft function rates, kidney donor profile index values, panel reactive antibodies levels, and insurance types were similar. Patients with public insurance were more frail. Despite increased early (< 6 months) rejection rates, 1-year patient and graft survival were similar. In Cox proportional hazards model, male sex, American Indian, Alaskan or Pacific Islander race, public insurance, and frailty category were independent risk factors for death at 1 year. Medicaid expansion was not associated with graft failure or patient survival (adjusted hazard ratio: 1.07; 95%CI: 0.26-4.41).
Medicaid expansion in Oklahoma is associated with increased KT access for non-White/non-Black and non-United States citizen patients with shorter wait times. 1-year graft and patient survival rates were similar before and after expansion. Medicaid expansion itself was not independently associated with graft or patient survival outcomes. Ongoing research is necessary to determine the long-term effects of Medicaid expansion.
尚无数据评估俄克拉荷马州医疗补助扩大计划对肾移植(KT)的影响。
调查俄克拉荷马州医疗补助扩大计划对KT患者的影响。
利用器官共享联合网络(UNOS)数据库评估医疗补助前后时代俄克拉荷马州成年KT受者的数据。采用双变量分析、Kaplan Meier分析进行估计,并使用Cox比例模型。
医疗补助扩大计划后时代有2758例之前的患者和141例受者。扩大计划实施后,患者中非美国公民的比例更高(2.3%对5.7%),美国印第安人、阿拉斯加人或太平洋岛民的比例更高(7.8%对9.2%),西班牙裔的比例更高(7.4%对12.8%),或亚洲人的比例更高(2.5%对8.5%)(P<0.0001)。扩大计划实施后等待名单时间更短(410±253天)(P=0.0011)。活体供体率、先发制移植、再次移植、移植肾功能延迟发生率、肾脏供体特征指数值、群体反应性抗体水平和保险类型相似。拥有公共保险的患者身体更虚弱。尽管早期(<6个月)排斥率有所增加,但1年时患者和移植物存活率相似。在Cox比例风险模型中,男性、美国印第安人、阿拉斯加人或太平洋岛民种族、公共保险和身体虚弱类别是1年时死亡的独立危险因素。医疗补助扩大计划与移植物失败或患者存活无关(调整后的风险比:1.07;95%置信区间:0.26 - 4.41)。
俄克拉荷马州的医疗补助扩大计划与非白人/非黑人及非美国公民患者获得KT的机会增加以及等待时间缩短有关。扩大计划前后1年的移植物和患者存活率相似。医疗补助扩大计划本身与移植物或患者存活结果无独立关联。有必要进行持续研究以确定医疗补助扩大计划的长期影响。